Tag: Richard Mulligan

  • Science & Tech

    ‘Any patient with any disease’

    Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”

    Chad Cowen
  • Health

    Sickle cell disease cured in mouse model

    Sickle cell disease is a blood disorder caused by a single mutation in the beta-globin gene that results in the substitution of one amino acid. This small error is enough…